首页> 外文期刊>Current radiopharmaceuticals >Production of high-purity radium-223 from legacy actinium-beryllium neutron sources
【24h】

Production of high-purity radium-223 from legacy actinium-beryllium neutron sources

机译:从传统的act-铍中子源生产高纯度镭223

获取原文
获取原文并翻译 | 示例
           

摘要

Radium- 223 is a short-lived alpha-particle-emitting radionuclide with potential applications in cancer treatment. Research to develop new radiopharmaceuticals employing 223Ra has been hindered by poor availability due to the small quantities of parent actinium- 227 available world-wide. The purpose of this study was to develop innovative and cost-effective methods to obtain high-purity 223Ra from 227Ac. We obtained 227Ac from two surplus actinium-beryllium neutron generators. We retrieved the actinium/beryllium buttons from the sources and dissolved them in a sulfuric-nitric acid solution. A crude actinium solid was recovered from the solution by coprecipitation with thorium fluoride, leaving beryllium in solution. The crude actinium was purified to provide about 40 milligrams of actinium nitrate using anion exchange in methanol-water-nitric acid solution. The purified actinium was then used to generate high-purity 223Ra. We extracted 223Ra using anion exchange in a methanol-water-nitric acid solution. After the radium was separated, actinium and thorium were then eluted from the column and dried for interim storage. This single-pass separation produces high purity, carrier-free 223Ra product, and does not disturb the 227Ac/ 227Th equilibrium. A high purity, carrier-free 227Th was also obtained from the actinium using a similar anion exchange in nitric acid. These methods enable efficient production of 223Ra for research and new alpha-emitter radiopharmaceutical development.
机译:Radium-223是一种短命的发射α粒子的放射性核素,在癌症治疗中具有潜在的应用前景。由于在全球范围内可利用的母体放线菌素227的数量很少,因此使用223Ra来开发新的放射性药物的研究受到了可用性的限制。这项研究的目的是开发创新且具有成本效益的方法,以从227Ac获得高纯度223Ra。我们从两台多余的in-铍中子发生器获得了227Ac。我们从来源中检索了in /铍纽扣,并将其溶解在硫酸-硝酸溶液中。通过与氟化or共沉淀从溶液中回收粗制的act固体,将铍留在溶液中。通过在甲醇-水-硝酸溶液中进行阴离子交换,纯化粗制的act以提供约40毫克的硝酸act。然后将纯化的act用于生成高纯度223Ra。我们在甲醇-水-硝酸溶液中使用阴离子交换提取了223 Ra。分离出镭后,然后从色谱柱上洗脱出in和th,并干燥以进行临时存储。这种单程分离可产生高纯度,无载体的223Ra产物,并且不会影响227Ac / 227Th平衡。在硝酸中使用类似的阴离子交换,还可以从the中获得高纯度,无载体的227Th。这些方法可有效生产223Ra,用于研究和新的α-发射体放射性药物开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号